U.S. Antimony director buys 12,500 UAMY shares
UNITED STATES ANTIMONY CORP director Jon R. Marinelli bought shares in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
UNITED STATES ANTIMONY CORP director Jon R. Marinelli bought shares in the company. On the reported date, he made an open-market purchase of 12,500 shares of Common Stock at a weighted average price of $7.45 per share.
After this transaction, Marinelli directly owned 12,500 shares. According to the filing, the shares were purchased in multiple trades at prices ranging from $7.41 to $7.50 per share.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 12,500 | $7.45 | $93K |
Footnotes (1)
- F1. The price reported in Column 4 is a weighted average purchase price. This shares were purchased in multiple transactions at prices ranging from $7.41 to $7.50, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
open-market purchase financial
weighted average purchase price financial
Common Stock financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Jon R. Marinelli report for UNITED STATES ANTIMONY CORP (UAMY)?
What type of transaction did the UAMY Form 4 report for Jon R. Marinelli?
Does the UAMY Form 4 footnote provide details on the purchase price breakdown?
AI-generated analysis. How Rhea-AI works. Not financial advice.